Advertisement

PharmacoEconomics & Outcomes News

, Volume 823, Issue 1, pp 1–1 | Cite as

ICER reports on spinal muscular atrophy and CVD therapies

News item
  • 6 Downloads

References

  1. 1.
    ICER. ICER's Assessment Finds Spinraza and Zolgensma Provide Substantial Health Benefits for People with Spinal Muscular Atrophy. Internet Document : 22 Feb 2019. Available from: URL: https://icer-review.org/announcements/sma_evidence_report/
  2. 2.
    ICER. ICER to Publish Upcoming Assessment on Additive Cardiovascular Disease Therapies. Internet Document : 22 Feb 2019. Available from: URL: https://icer-review.org/announcements/additive-cvd-topic/

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations